Page results
-
Our non-emergency patient transport service is provided by G4S. G4S may use approved external sub-contractors to meet the demand of the service and/or the specific needs of our patients.
-
The tissue viability team is committed to providing support, training and education to clinical staff, patients and carers about maintaining, promoting skin integrity and preventing pressure sores.
-
For patients aged 13-18 we have a dedicated team covering a range of conditions, particularly specialising in reconstructive urology.
-
A safeguarding clinic dedicated to the long term needs of children and young people who have problems related to Sexual, gynaecological or genito-urinary health, Complex maltreatment including sexual abuse, female genital mutilation, factitious illness and related issues. We also see unaccompanied children, refugees and looked after children.
-
Our nationally-recognised service helps children and young people (up to 19 years) with type 1 diabetes, type 2 diabetes, monogenic diabetes such as maturity onset diabetes in the young (MODY) and steroid related diabetes.
-
Four women have successfully had combined surgery at UCLH in which they gave birth by caesarean section and at the same time had surgery to reduce their risk of ovarian cancer.
-
Information about total penectomy and perineal urethrostomy for patients referred to UCLH.
-
UCLH cancer services are closely located in and around University College Hospital, which is a one-minute walk from Warren Street and Euston Square tube stations. It’s a 15-minute walk from London King’s Cross St Pancras and Euston stations, and a few minutes on the Circle Line from Paddington Station.
-
Patient information for patients suffering from long COVID who are returning to work.
-
Information about the EGA Hospital Charity at UCLH
File results
-
FOI/2023/0296 - Consultant workforce information
-
FOI/2023/0300 - Post-mortem examinations for 2019, 2020, 2021 and 2022
-
FOI/2023/0301 - Meat served at the Trust that may contain nitrates or nitrites
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0344 - Number of neonatal and stillbirth deaths since January 2013
-
FOI/2023/0352 - Data security training, data breach reporting, security budgets
-
FOI/2023/0345 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer